Strides Pharma Science

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue1,2481,3021,3321,2701,434
Expenses1,0851,0531,1791,1331,283
EBITDA258.70342.80247.84234.67255.00
EBIT199.25288.86189.63240.18196.98
Profit Before Tax153.11245.47148.05199.61150.44
Net Profit131.52208.12129.28165.49134.12
Financial Ratios
Operating Profit Margin20.39%28.42%18.35%23.44%17.78%
Net Profit Margin11.06%17.15%10.01%8.26%9.25%
Earning Per Share (Diluted)13.8421.9213.7717.0214.19
Dividends Per Share0.000.000.000.000.00